MedPath

海南制药厂有限公司

Ownership
-
Established
2001-07-09
Employees
-
Market Cap
-
Website
https://www.hnzyc.cn

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

172

NMPA:172

Drug Approvals

Cyproheptadine Hydrochloride

Product Name
盐酸赛庚啶
Approval Number
国药准字H20083181
Approval Date
Oct 18, 2024
NMPA

Berberine Hydrochloride

Product Name
盐酸小檗碱
Approval Number
国药准字H46020085
Approval Date
Jul 30, 2024
NMPA

Rauwolfia

Product Name
萝芙木
Approval Number
国药准字H46020639
Approval Date
Jul 22, 2024
NMPA

Ethacridine Lactate Solution

Product Name
乳酸依沙吖啶溶液
Approval Number
国药准字H46020545
Approval Date
Jul 19, 2024
NMPA

复方木麻黄胶囊

Approval Number
国药准字Z20080426
Approval Date
Jul 27, 2023
NMPA

妇科止带片

Approval Number
国药准字Z20083267
Approval Date
May 25, 2023
NMPA

一清软胶囊

Approval Number
国药准字Z20080156
Approval Date
May 16, 2023
NMPA

Sulfadiazine Tablets

Product Name
磺胺嘧啶片
Approval Number
国药准字H46020062
Approval Date
Oct 13, 2020
NMPA

Vitamin C Injection

Product Name
维生素C注射液
Approval Number
国药准字H46020165
Approval Date
Oct 12, 2020
NMPA

Sulfadiazine Sodium Injection

Product Name
磺胺嘧啶钠注射液
Approval Number
国药准字H46020166
Approval Date
Sep 29, 2020
NMPA
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 18
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.